Jama Editors' Summary: On Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinicians.
Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and more
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:51
- Mas informaciones
Informações:
Sinopsis
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 1-7, 2025.